H1 2022 MedTech Review

We are pleased to share this review of MedTech sector revenue growth, VC funding, and exits (M&A and IPO activity)

In this report you will find an overview of the following:

  • Revenue growth for public companies in FSI’s MedTech segments from 2019 through H1 2022
  • FSI’s view of key trends and commentary from leading MedTech companies  
  • Analysis of VC investments, M&A, and IPOs in medical devices/supplies and diagnostics/life science tools  

Download the complete report: